Viewing Study NCT01847768


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2025-12-28 @ 1:07 AM
Study NCT ID: NCT01847768
Status: TERMINATED
Last Update Posted: 2015-08-14
First Post: 2013-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Human Rhinovirus Infection and Airway Remodeling Mediators
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Overview

Official Title: Comparison of Airway Remodeling Mediators Following Experimental Human Rhinovirus Infection in Subjects With Mild to Moderate Asthma, and in Healthy, Non-asthmatic Control Subjects (AADCRC-UC-01)
Status: TERMINATED
Status Verified Date: 2015-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Lack of Enrollment
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In this study, the following subjects will be exposed to human rhinovirus (HRV):

* those with classification of mild-moderate asthma
* healthy control subjects.

The investigators will study the kinetics of HRV-induced inflammatory and remodeling responses in a well characterized group of asthmatic subjects and compare these outcomes to those in a healthy, non-asthmatic control group.
Detailed Description: Although changes in the lungs, known as remodeling, are a feature of asthma, the causes and mechanisms involved in the process have not yet been found. Recently, it has been established that remodeling can be observed in children prior to a formal diagnosis of asthma. Clinical studies indicate that HRV, "common cold" infections, are a common cause of recurrent respiratory illnesses in childhood, and children with HRV-associated wheezing episodes have an increased risk of developing asthma. This led to the hypothesis that HRV infections may play a central role in the start of the airway remodeling leading to asthma.

The goal of this study is to determine if alterations in relevant airway remodeling growth factors differ between healthy controls and asthmatic subjects, pre- and post-HRV infection. These growth factors will be assessed in bronchoalveolar lavage (BAL) fluid and endobronchial biopsy tissues and correlated with viral levels in both nasal lavage and BAL fluid.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
AADCRC-UC-01 OTHER Asthma and Allergic Diseases Cooperative Research Centers View